KIORA PHARMACEUTICALS, INC. Proceeds from Issuance or Sale of Equity
KIORA PHARMACEUTICALS, INC. (KPRX) reported Proceeds from Issuance or Sale of Equity of $10.10 million for the 1-month period ending 2018-04-17, per its 10-Q filed 2019-05-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2021-03-25
- 2018-04-17: Proceeds from Issuance or Sale of Equity $10.10M; Proceeds from Issuance or Sale of Equity 1 month $10.10M.
- 2017-06-14: Proceeds from Issuance or Sale of Equity $8.80M; Proceeds from Issuance or Sale of Equity 0 month $8.80M.
- 2016-06-30: Proceeds from Issuance or Sale of Equity 1 month $3.40M; Proceeds from Issuance or Sale of Equity 6 month $3.40M.
| Period end | Proceeds from Issuance or Sale of Equity | Proceeds from Issuance or Sale of Equity 0 month | Proceeds from Issuance or Sale of Equity 1 month | Proceeds from Issuance or Sale of Equity 6 month |
|---|---|---|---|---|
| 2018-04-17 | $10.10M 10-K · filed 2021-03-25 | $10.10M 10-Q · filed 2019-05-08 | ||
| 2017-06-14 | $8.80M 10-K · filed 2020-03-04 | $8.80M 10-Q · filed 2019-05-08 | ||
| 2016-06-30 | $3.40M 10-K · filed 2018-03-02 | $3.40M 10-Q · filed 2016-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |